Biofortis will make a bioinformatic presentation at the PRI Pharmabiotics event – March 14-15, 2018, Paris, FRANCE17/10/2017
Acute myeloid leukemia (AML) : what’s new?17/10/2017
Join CTI Biotech in Bulgaria !
On the 3rd and 4th November, Professor McGuckin and Dr Forraz will attend the Bulgarian Association for Personalized Medicine – BAPEMED conference in Plovdiv University, Bulgaria. They will hold two oral communication on methods and development of personalized medicine in oncology. This will provide a great opportunity to showcase the IMODI consortium as well as its products and services. BAPEMED is a not for profit Bulgarian organization with diverse members : health care professionals, patients, and scientists in research or commercial structures fostering the better understanding and adoption of the concept, services and products of personalized medicine for the benefit of the patients.
2D/3D in vitro cell based bioassays to accelerate personalized medicine in cancer therapy
Dr Nico FORRAZ, CEO CTIBIOTECH, Vice President of Cell Therapy Research Institute, Lyon, France
The use of 3D Bioprinting for cancer research and cell based models
Professor Colin McGUCKIN, Chairman and CSO CTIBIOTECH, President of Cell Therapy Research Institute, Lyon, France
Please, join us in Bulgaria !
IMODI is now present on the Twitter and LinkedIn networks.
Follow us on @IMODI_Cancer